About Us | Fabric Genomics

Fabric Genomics: enabling precision medicine with market-leading, AI-driven genomic interpretation

At Fabric Genomics, our vision is to make it possible for all patients to have genomics-driven precision medicine. We enable clinicians to truly deliver on precision medicine by quickly and accurately interpreting genomic data and using those insights to diagnose and treat patients. Fabric is transforming precision medicine by combining the vast quantities of genomic data with often complex phenotypic data to predict risk, diagnose disease, and plan treatment for even the most challenging cases. 

Fabric’s technology sets a new standard in diagnostic accuracy and speed

With results that are far superior to other AI solutions, Fabric AI is an order of magnitude more effective and faster than competing pipelines.

Deriving clinical utility from genomic information is the quintessential big-data problem – vast quantities of data are returned for each patient, and with the exponential growth in NGS, a technology solution is essential. Fabric Genomics has pioneered AI-driven, scalable genomic interpretation with a suite of groundbreaking algorithms. This approach unlocks diagnostic yields better than previously imagined, and this accuracy enables a whole new level of speed and throughput to be achieved. Fabric uniquely provides a comprehensive AI-based solution that spans the range of NGS applications from targeted panels to exomes and whole-genome sequencing. Fabric was the first to offer a commercial algorithm for diagnostic genomic interpretation and has partnered with leading NGS labs and major hospital systems to bring these groundbreaking advances to patients at over 50 sites running tens of thousands of tests per year. 

AI-based solutions spanning NGS applications

Fabric uniquely provides a comprehensive AI-based solution that spans the range of NGS applications from targeted panels to exomes and whole-genome sequencing. Fabric was the first to offer a commercial algorithm for diagnostic genomic interpretation and has partnered with leading NGS labs and major hospital systems to bring these groundbreaking advances to patients at over 50 sites running tens of thousands of tests per year.

Seed funding

2009
Publishing of VAAST
June 2011
Publishing of Phevor
April 2014
Guiness Record/Rady
February 2018
ACE Release

March 2019
GEM Release

October 2020

Fabric’s management team is made up of key leaders from the genomics revolution.

Martin Reese, CEO, Francisco de la Vega, CSO, and SVP of Research, Charlene Son Rigby, Chief Business Officer, and its board of directors, Paul Billings and John Stuelpnagel and Developer Mark Yandell, are key innovators in the genomics and diagnostic industry. Between them, they have founded such companies as Illumina, Neomorphic (acquired by Affymetrix), and 10x Genomics, led large teams at DoubleTwist, Applied Biosystems and Oracle and played critical roles in landmark projects in genomics such as BDGP, GASP, 1000 Genomes,1700 Human array, and the SNPlex™Genotyping system. 

Leadership

Martin Reese, Ph.D. headshot

Martin Reese, Ph.D.

Co-Founder, President, and CEO

Read more
John Stuelpnagel, D.V.M headshot

John Stuelpnagel, D.V.M

Co-Founder, Chairman of the Board of Directors

Read more
Paul Billings headshot

Paul Billings, M.D., Ph.D.

Co-Founder and Acting Chief Medical Officer

Read more
Charlene Son Rigby headshot

Charlene Son Rigby

Chief Business Officer

Read more
Francisco De La Vega headshot

Francisco De La Vega

Chief Scientific Officer, SVP of R&D

Read more

Michael Vishnevetsky, Ph.D.

Vice President of Business Development

Scientific & Medical Advisory Board

Edward Kiruluta

Edward Kiruluta

Co-Founder, Fabric Genomics

Mark Yandell, PhD headshot

Mark Yandell, Ph.D.

University of Utah & USTAR Center for Genetic Discovery

Thomas Quertermous headshot

Thomas Quertermous, M.D.

Stanford University Cardiovascular Medicine & VIA Pharmaceuticals

Paul Flicek headshot

Paul Flicek, D.Sc.

European Bioinformatics Institute

Joshua Schiffman

Joshua Schiffman, M.D.

University of Utah School of Medicine & Huntsman Cancer Institute

Gholson Lyon

Gholson Lyon, M.D., Ph.D.

Institute for Basic Research in Developmental Disabilities (IBR)

Geoff Ginsburg

Geoffrey S. Ginsburg, M.D., Ph.D.

Duke Center for Applied Genomics and Precision Medicine & Global Genomic Medicine Collaborative

Lee Hood headshot

Leroy Hood, M.D., Ph.D.

Institute for Systems Biology & University of Washington

Board

Martin Reese, Ph.D. headshot

Martin Reese, Ph.D.

Co-Founder, President, and CEO

John Stuelpnagel, D.V.M headshot

John Stuelpnagel, D.V.M

Co-Founder, Chairman of the Board of Directors

Jim Tananbaum, M.D.

Board Member

Investors

Artis
Roche
UPMC
PING
LDV Partners

Discover how Fabric Genomics can help you
succeed with NGS testing